Showing results (51-60 of 129) with videos related to
Sort By:
Pageof 13
Cancer|November 1, 1976
Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor. Case reportD Kessel, M K Samson, P Shah, et al.Cancer Clinical Trials|January 1, 1979
Use of VM-26 as a single agent in the treatment of renal carcinomaE A Hire, M K Samson, R J Fraile, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1B J Foster, R A Wiegand, P M LoRusso, et al.Cancer Treatment Reports|September 1, 1983
Gallium nitrate in malignant lymphoma: a Southwest Oncology Group studyJ K Weick, R L Stephens, L H Baker, et al.Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.Journal of General Internal Medicine|March 1, 1996
Effects of a physician communication intervention on patient care outcomesS K Joos, D H Hickam, G H Gordon, et al.Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.Cancer|November 1, 1977
Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group reportC Leite, J W Goodwin, J G Sinkovics, et al.Antimicrobial Agents and Chemotherapy|March 1, 1976
Use of clindamycin in patients with liver diseaseD R Hinthorn, L H Baker, D A Romig, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Clinical pharmacokinetics of high-dose mitomycin CR B Schilcher, J D Young, V Ratanatharathorn, et al.Pageof 13